Position in ACB
as of Sep 30, 2022
· filed Oct 7, 2022
Position Value
$2,592
-$213 QoQ
Shares Held
212
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Sep 30, 2022American Research & Management Co. holds $104,529 across 8 Drug Manufacturers - Specialty & Generic names. ACB ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
215 | $31,882 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
135 | $28,266 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,000 | $25,940 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
104 | $5,531 | |
| 5 | TLRY |
Tilray Brands, Inc.
|
181 | $4,988 | |
| 6 | HLN |
Haleon plc
|
478 | $2,911 | |
| 7 | ACB |
Aurora Cannabis Inc
This page
|
212 | $2,592 | |
| 8 | VTRS |
Viatris Inc
|
284 | $2,419 |
All Filings in ACB
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2022-09-30 | $2,592 | 2,125 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $2,805 | 2,125 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $8,500 | 2,125 | Shares | Sole | 2022-04-21 | |
| No filing history on record for this holder in this stock. | ||||||